Low Molecular Weight Dextran-Reference-Cited by-同舟云学术

Low Molecular Weight Dextran

Published:1967-09 Issue:5 Volume:51 Page:1285-1299
ISSN:0025-7125
Container-title:Medical Clinics of North America
language:en
Short-container-title:Medical Clinics of North America

Author:

Evarts Charles M.

Publisher

Elsevier BV

Subject

General Medicine

Reference110 articles.

1. Use of low molecular weight dextran to prolong bowel viability in strangulation obstruction (Abst.). Fifty Multidiscipline Research Forum of the American Medical Association;Anderson;J.A.M.A,1965

2. Low molecular weight dextran therapy in experimental pancreatitis;Anderson;JA.M.A,1965

3. Renal excretion of low molecular weight dextran;Arturson;Acta Chir. Scandinav,1964

4. Intravascular persistence of dextran of different molecular sizes in normal humans;Arturson;Scand. J. Clin. Lab. Invest,1964

5. Renal clearance of dextran of different molecular sizes in normal humans;Arturson;Scandinav. J. Clin. Lab. Invest,1964

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. α-Glucan derivatives as selective blockers of aldolase A: Computer-aided structure optimization and the effects on HCC;Carbohydrate Polymers;2024-02

2. Mechanical Prophylaxis: Bacterial Colonisation and Sterilisation;HIP International;2003-01

3. Lesson of the week: Pneumatic compression boots for prophylaxis against deep vein thrombosis: beware occult arterial disease;BMJ;1998-02-07

4. Lung lymph oncotic pressure may not modulate pulmonary vascular filtration in sheep.;American Journal of Respiratory and Critical Care Medicine;1997-03

5. Hapten resistant dextran induced ARDS reaction following intracoronary stent deployment;Catheterization and Cardiovascular Diagnosis;1996-05